CORRIGENDUM to 'Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis'

Cephalalgia. 2022 Jan;42(1):90. doi: 10.1177/03331024211042798. Epub 2021 Sep 14.
No abstract available

Publication types

  • Published Erratum